---
id: FC-352
type: Flashcard
created: 2025-08-08 10:02:00.380973
tags:
- Flashcard
- question
- endocrine
topic: endocrine
answer: A
related_articles:
- title: 'Pulmonary Nodules: Common Questions and Answers.'
  path: 2023/2023-03-pulmonary-nodules-common-questions-and-answers.md
  similarity: 0.438
  link: '[[2023/2023-03-pulmonary-nodules-common-questions-and-answers|Pulmonary Nodules:
    Common Questions and Answers.]]'
- title: Lung Cancer-Related Mortality and the Impact of Low-Dose Computed Tomography
    Screening.
  path: 2023/2023-05-lung-cancer-related-mortality-and-the-impact-of-low-dose-com.md
  similarity: 0.4
  link: '[[2023/2023-05-lung-cancer-related-mortality-and-the-impact-of-low-dose-com|Lung
    Cancer-Related Mortality and the Impact of Low-Dose Computed Tomography Screening.]]'
- title: ASCCP Management Guidelines for Abnormal Cervical Cancer Screening.
  path: 2024/2024-03-asccp-management-guidelines-for-abnormal-cervical-cancer-scr.md
  similarity: 0.389
  link: '[[2024/2024-03-asccp-management-guidelines-for-abnormal-cervical-cancer-scr|ASCCP
    Management Guidelines for Abnormal Cervical Cancer Screening.]]'
- title: 'Lung Cancer Screening: Guidelines From the American College of Chest Physicians.'
  path: 2023/2023-01-lung-cancer-screening-guidelines-from-the-american-college-o.md
  similarity: 0.375
  link: '[[2023/2023-01-lung-cancer-screening-guidelines-from-the-american-college-o|Lung
    Cancer Screening: Guidelines From the American College of Chest Physicians.]]'
- title: Screening for Chronic Obstructive Pulmonary Disease.
  path: 2024/2024-11-screening-for-chronic-obstructive-pulmonary-disease.md
  similarity: 0.357
  link: '[[2024/2024-11-screening-for-chronic-obstructive-pulmonary-disease|Screening
    for Chronic Obstructive Pulmonary Disease.]]'
topics:
- Cardiology
- Endocrinology
- Geriatrics
- Orthopedics
- Psychiatry
---

# Flashcard FC-352

## Question

A66-year-oldwomanwithahistoryofobesityhasadual-energyx-rayabsorptiometry(DEXA)T-scoreof -2.5. Shehadapulmonaryembolismsixmonthsagoandrecentlystoppedheranticoagulanttherapy. Shehasnohistoryoffractureanddoesnothaveanelevatedfracturerisk(riskassessmentscoreis2). according to the American Collegeof Obstetriciansand Gynecologists(ACOG),whichoneofthe followingtreatmentsisthemostappropriate? Alendronate,abisphosphonate. Raloxifene,aselectiveestrogenreceptormodulator. Romosozumab,asclerostin-bindinganalog. Teriparatide,aparathyroidhormoneanalog. @ Back

## Answer

**A**

## Explanation

Apatientwitha DEXAT-scoreof-2.5 isconsideredtohaveosteoporosisandshould betreated. Bisphosphonatesareconsideredfirst-linetherapyforpatientswithosteoporosis. Raloxifeneisasecond-linetreatmentrecommendedforthosewithosteoporosisandanincreasedriskof breastcancer,butthispatientshistoryofvenousthromboembolismmakesthismedicationinappropriate. Becauseshedoesnothaveanelevatedfracturerisk,historyoffracture,ora T-scoreof-3.0 orless,a parathyroidhormoneanalogorsclerostin-bindinganalogisnotindicatedasfirst-linetherapy. e

## References

- AAFPQuestion Bank-Pythonsimplecapture.
- ACOG),whichoneofthe

